GlassScriptPhysician profile
Bridgette J Parish
NPI 1114158672
$2,988.11
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.34 · 2020: $414 · 2021: $701 · 2022: $882 · 2023: $794 · 2024: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $624.52 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $348.61 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $280.70 | 2021-2023 | |
| Exeltis, USA INC. | $173.70 | 2020-2023 | Slynd |
| Sumitomo Pharma America, INC. | $171.69 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $141.84 | 2021-2022 | |
| Radius Health, INC. | $109.56 | 2020-2024 | Tymlos |
| Organon LLC | $99.50 | 2021-2024 | Nexplanon |
| Lupin INC. | $90.52 | 2019-2021 | |
| Astellas Pharma US INC | $88.75 | 2023 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $87.15 | 2019-2022 | |
| Amgen INC. | $85.00 | 2020-2022 | |
| Coopersurgical, INC. | $75.90 | 2021-2024 | Paragard T 380a |
| Shield Therapeutics INC | $72.24 | 2022-2023 | Accrufer |
| Pfizer INC. | $46.10 | 2021-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $45.34 | 2021 | |
| Evofem Biosciences, INC. | $41.39 | 2021 | |
| Ethicon US, LLC | $38.02 | 2022 | |
| Medicem INC. | $34.52 | 2020-2021 | |
| Millicent US INC | $34.18 | 2020-2021 | |
| Exact Sciences Corporation | $33.73 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $33.08 | 2021-2023 | Truclear |
| Therapeuticsmd, INC. | $31.45 | 2019-2020 | |
| Lsi Solutions INC | $26.04 | 2023 | Fornisee |
| Smith+Nephew, INC. | $24.80 | 2023 | Pico 7 |
| Aspira Women'S Health INC | $23.82 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $23.70 | 2022 | |
| Mylan Pharmaceuticals INC. | $18.14 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.63 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $16.82 | 2023 | Vivjoa |
| Agile Therapeutics, INC. | $15.97 | 2022 | |
| Scynexis, INC. | $12.20 | 2022 | |
| Renovia INC | $11.19 | 2019 | |
| Meditrina | $10.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgette Parish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.